Amicus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,550	4,426	2,815	4,166	3,432	3,221
Market Cap Growth	132.87%	57.26%	-32.44%	21.38%	6.55%	-46.76%
Enterprise Value	4,699	4,567	3,000	4,317	3,582	3,172
Last Close Price	14.49	14.24	9.42	14.19	12.21	11.55
PE Ratio	-	-158.22	-52.33	-27.82	-14.89	-12.55
Forward PE	39.70	59.68	87.63	-	-	-
PS Ratio	7.17	6.98	5.33	10.43	10.43	10.54
PB Ratio	16.42	16.14	14.51	26.01	27.89	10.48
P/TBV Ratio	16.32	16.01	14.78	26.15	28.68	10.20
P/FCF Ratio	152.43	148.29	-75.17	-54.44	-20.15	-15.61
P/OCF Ratio	137.27	133.55	-83.05	-60.30	-20.61	-15.91
EV/Sales Ratio	7.41	7.20	5.68	10.81	10.88	10.38
EV/EBITDA Ratio	112.00	113.46	89.76	-62.25	-17.32	-15.84
EV/EBIT Ratio	136.23	139.27	120.60	-55.91	-16.89	-15.36
EV/FCF Ratio	157.42	152.99	-80.12	-56.40	-21.03	-15.37
Debt / Equity Ratio	1.58	1.58	2.24	2.73	3.60	1.41
Debt / EBITDA Ratio	10.99	10.99	13.27	-6.42	-2.19	-2.20
Debt / FCF Ratio	14.82	14.82	-11.85	-5.81	-2.65	-2.13
Net Debt / Equity Ratio	0.54	0.54	1.00	0.99	1.29	-0.14
Net Debt / EBITDA Ratio	3.70	3.70	5.80	-2.29	-0.77	0.21
Net Debt / FCF Ratio	4.99	4.99	-5.17	-2.08	-0.93	0.21
Asset Turnover	0.73	0.73	0.68	0.53	0.40	0.34
Inventory Turnover	0.42	0.42	0.59	0.89	1.52	1.49
Quick Ratio	1.72	1.72	2.36	2.23	2.59	3.67
Current Ratio	2.84	2.84	3.39	2.88	3.05	4.09
Return on Equity (ROE)	-11.58%	-11.58%	-31.68%	-107.04%	-109.93%	-84.37%
Return on Assets (ROA)	-536.51%	-536.51%	6.21%	-10.38%	-25.45%	-23.89%
Return on Invested Capital (ROIC)	-1132.23%	-1132.23%	13.35%	-23.85%	-66.40%	-72.27%
Return on Capital Employed (ROCE)	4.86%	4.86%	3.99%	-12.92%	-31.56%	-27.23%
Earnings Yield	-0.60%	-0.63%	-1.91%	-3.59%	-6.72%	-7.97%
FCF Yield	0.66%	0.67%	-1.33%	-1.84%	-4.96%	-6.41%
Buyback Yield / Dilution	-1.31%	-1.31%	-3.12%	-2.11%	-6.50%	-4.85%
Total Shareholder Return	-1.31%	-1.31%	-3.12%	-2.11%	-6.50%	-4.85%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q